Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsInfectious Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1103559

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1103559

COVID-19 Testing

PUBLISHED:
PAGES: 1417 Pages
DELIVERY TIME: 1-2 business days
Get a Free Sample
Get More Info
SELECT AN OPTION
PDF (Single User License)
USD 5800
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17400

Add to Cart

Description

Table of Contents

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass Research Platform

» Complimentary updates for one year

Global COVID-19 Testing Market to Shrink to $8.0 Billion by 2027

In the changed post COVID-19 business landscape, global market for COVID-19 Testing estimated at US$19 Billion in the year 2020, is projected to decline to US$8.0 Billion by 2027, declining at a CAGR of -11.8% over the analysis period 2020-2027.

COVID-19 testing has emerged as a large market in a span of few months owing to the large-scale testing across the world. However, with vaccines being launched across the world, the COVID-19 testing market is expected to slowdown in 2021, and decline rapidly in the near future as the global population starts getting vaccinated. The major testing types include RT-PCR tests, rapid antigen tests, and rapid antibody tests. Growth in the global market is primarily being driven by rising incidence of COVID-19 infection and the pressing need for effective and fast testing. Announced as pandemic by the WHO, the rapid spread of the virus across countries has prompted governments to rely on massive testing, which created strong demand for COVID-19 test kits. The market for these tests is further bolstered by unavailability of an effective treatment hitherto, driving people to consider diagnostic testing as a solution to curtail the pandemic. Increase caseloads of COVID-19 owing to non-compliance to specific measures like social distancing has resulted in significant demand for testing. In addition, the requirement of effective detection kits for vulnerable population, including aging people and individuals with the compromised immune system, is propelling the market. On the other hand, short supply of test kits and other components, such as RT-PCR instruments, virus control samples, and swabs, are expected to limit the market growth.

Select Competitors (Total 547 Featured) -

  • 3D Biomedicine Science & Technology Co., Limited
  • Abbott Laboratories
  • Advaite, Inc.
  • AlphaBiolabs Ltd
  • BGI Genomics Co. Ltd.
  • BioFire Diagnostics LLC
  • BioMedomics Inc
  • Bioscience (Tianjin) Diagnostic Technology Co., LTD
  • Cellex
  • Cepheid Inc.
  • Chembio Diagnostic Systems, Inc.
  • Co-Diagnostics Inc.
  • Dynamiker Biotechnology (Tianjin) Co., Ltd.
  • GenMark Diagnostics, Inc.
  • Hologic, Inc
  • Innovita Biological Technology Co., Ltd
  • Mayo Clinic Laboratories
  • Mylab Discovery Solutions Pvt. Ltd.
  • Ortho Clinical Diagnostics
  • Primerdesign Ltd
  • QIAGEN N.V.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Safecare Biotech(Hangzhou) Co., Ltd.
  • SD Biosensor
  • Seegene Inc.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific
  • Zhejiang Orient Gene Biotech Co., LTD
Show more
Product Code: MCP16930

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

Influencer Market Insights

World Market Trajectories

  • 1. GLOBAL MARKET OVERVIEW
    • Types of COVID-19 Testing
    • Different Types of Coronavirus Tests
    • Performance Analysis of COVID-19 Tests
    • Rapid Tests Help in Controlling the Virus
    • How Will COVID-19 Testing Change in 2021
    • Massive Testing to Become a Way of Life
    • COVID-19 to Drive Hospital and Diagnostic Lab Revenues in 2021
    • COVID-19 Testing Witnesses Staggering Growth Due to Rising Incidence of Corona Virus
    • Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of September 1st, 2021
    • Total Number of COVID-19 Tests Worldwide in Select Countries: As of September 1st, 2021
    • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
    • Select Approved COVID-19 Molecular Assay Tests
    • Immunoassays to Witness Fastest Growth
    • Increasing Demand for Antibody Tests
    • How Antibody (Serology) Tests Were Approved and Developed
    • Select COVID-19 Immunoassay Kits
    • List of US FDA Approved Antigen Tests
    • Nasopharyngeal/Oropharyngeal Swabs Remain Primary Sample Type
    • Diagnostic Laboratories Constitute the Largest End-use Segment
  • RECENT MARKET ACTIVITY
    • Recent Launches
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS AND ISSUES
    • Rising Incidence of Coronavirus Cases Drive the Need for Testing
    • COVID-19 Most Impacted 18 Countries Worldwide: As on September 1st, 2021
    • Pandemic Gives Rise to Innovative Partnership Models
    • Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics
    • Increasing Point-of-Care Molecular Testing
    • Accelerated Development and Faster Adoption of New Technologies
    • Expansion of Manufacturing Capacity in Asia and Shift of Supply
    • Positioning for the Future
    • Some Innovative Testing Methods for COVID-19:
  • CRISPR
    • Bioluminescence Testing
    • Lab-on-chip Testing
    • LAMpore Kits
    • Covid-19 NudgeBox Test by DNANudge
    • High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Rapid Test Kits Market for COVID-19 to Exhibit Exponential Growth
    • Select Approved COVID-19 Rapid Tests
    • Point-of-Care Tests Witness Rapid Growth
    • High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
    • Mass Community Testing Holds the Key for Effective COVID-19 Management
    • The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms
    • CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
    • Innovations and Approvals
    • Portable PoC Test with a Smartphone Reader
    • Saliva Test
    • FDA Approves First Molecular Test for Asymptomatic Patients
    • New Molecular Test N1-STOP-LAMP
    • LumiraDx SARS-CoV-2 Antigen Test
    • Integration of Sophisticated Technology to Drive Market Growth
    • Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing
    • In-home Testing for Covid-19
    • FDA Authorizes Home Collection Option for LabCorp's COVID-19 Diagnostic Test
    • A Rapid Genomics Strategy to Trace Coronavirus
    • The pioneering of Rapid Genomics
    • Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic
    • Digital Technologies Gaining Adoption Amid COVID-19
    • List of COVID-19 Contact Tracing Apps
    • Amazon Offers FDA-Approved COVID-19 Test
    • Alliance of BMGF and Life Science Companies Pledge to Improve Access
    • Ensuring the Perfect Mix of COVID-19 Testing
    • Testing Rate & Average Turnaround Time to Results as Key Metrics
    • Growing Significance of Pooled Testing
    • Participation of Public & Private Sector
    • Avoiding Supply Mismatch
    • Recent Launches
    • New Test Detects SARS-CoV-2 in Less Than Five Minutes
    • New COVID-19 Test Provides Faster Results and Eliminates False Negatives
    • New Rapid Lateral Flow Immunoassay Developed
    • University of California Develops Rapid, Accurate Testing for SARS-CoV-2 Antibodies
    • Abbott Plans Shipment of Tens of Millions of At-Home Coronavirus Tests Costing $25 in Early 2021
    • Quidel Gains FDA Approval for Sofia 2 Antigen Test
    • Improving Medicine with Innovation and Technology and Massachusetts Institute of Technology Develop COVID-19 Testing Impact Calculator (U.S.)
    • Nanomix Offers eLab COVID-19 Rapid Antigen Test
    • Abbott Receives FDA Approval for BinaxNow
    • Roche Introduces Elecsys® SARS-CoV-2 Antigen test
    • DnaNudge Offers CovidNudge Test
    • Open-Source Toolkit Helps Developing Countries Meet Demand for COVID-19 Diagnostics
    • 3M Joins Hands with MIT's Sikes Lab to Create Rapid & Affordable COVID-19 Test
    • ZTA Biotech Announces "Breakthrough" Development with Antibody Test
    • Molecular Diagnostics Firm QuantuMDx Group Set to Scale up Production of Rapid PCR COVID-19 Device
    • Mologic Granted CE Mark for Rapid Antigen Test
    • FDA Approves Abbott's COVID-19 Antigen Test
    • AptameXTM
    • COVID-19 Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Market Prospects and Outlook
    • US and Europe Dominate, Asia-Pacific to Witness Fastest Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2021 & 2027
    • TABLE 3: World Recent Past, Current & Future Analysis for RT-PCR Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for RT-PCR Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Test Strips/Cassettes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Immunoassay Test Strips/Cassettes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 7: World Recent Past, Current & Future Analysis for Nasopharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Nasopharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 9: World Recent Past, Current & Future Analysis for Oropharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Oropharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 11: World Recent Past, Current & Future Analysis for Nasal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Nasal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Specimen Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Specimen Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
    • Market Analysis
    • US Emerges as a Major Market for COVID-19 Tests
    • New Delta Variant Cases Cause Concern
    • Covid-19 Test Supply Chain Issues in the US
    • Challenges Associated with COVID-19 Testing
    • Impact of Surveillance Testing on COVID-19 Test Supply Chain
    • CDC Funding for Covid-19 Vaccination & Testing-Related Activities
    • Escalating Cases of COVID-19 Lead to Spurt in Diagnostic Test Innovations
    • Uptake of At-Home Tests Remains Modest
    • FDA Approves 2 Rapid, At-Home Coronavirus Tests
    • Select Point Of Care Home Tests in the US
    • Pharmacies Now Offering Over-The-Counter Same-day COVID Tests
    • HHS Introduces Pilot Program for Cartridge-based Covid-19 Molecular Test Kits
    • Oura Develops New Smart Ring to Detect Covid-19 Symptoms at Early Stage (Finland)
    • Issues with Existing Testing Options
    • Issues with At-Home and Point-of-Care Rapid Tests
    • Disparate Costs Continue to Plague US Covid-19 Testing
    • With Spike in COVID-19 Cases Roiling Testing Efforts, NIH Eyes on Rapid Tests to Push Capacity
    • Promising Technologies under RADx Program
    • Rapid COVID Tests: Important Tool for Recovery
    • California University Installs Vending Machines to Dispense COVID-19 Testing Kits to Students
    • FDA Assumes Lukewarm Stance to Home Tests despite COVID-19 Testing Lag in US
    • CMS Prioritizes Covid-19 Testing: Announces New Reimbursement Rules
    • CMS Decreases Price for High-Throughput Technology-Based Covid-19 Testing
    • Ageing Demographics: A Major Driving Factor
    • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • NIH Funding
    • US FDA Approved COVID-19 Tests
    • Select US FDA Approved COVID-19 Tests (As of August 31, 2021)
    • TABLE 21: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 22: USA 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 23: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 24: USA 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 25: USA Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • CANADA
    • Market Analysis
    • New Cheaper and Faster COVID-19 Rapid Test Kit Obtains Approval
    • Canada Approves First Antigen-Based Rapid COVID-19 Test
    • Government of Ontario Introduces Covid-19 Screening Tests at Toronto Pearson International Airport
    • New Federal Rule in Canada for Air Passengers' COVID-19 Tests
    • TABLE 27: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 28: Canada 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 29: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Canada 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 31: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • JAPAN
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
    • Market Analysis
    • Japan Moves to Low-Cost PCR Testing
    • Rapid Testing Still Costs a Bomb
    • Medical Clinics Edge
    • TABLE 33: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Japan 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 35: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Japan 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 37: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • CHINA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
    • China's Qingdao Embarks on Ambitious Mission to Test Entire Population of City for COVID-19 in Five Days
    • TABLE 39: China Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 40: China 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 41: China Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 42: China 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 43: China Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • EUROPE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
    • Market Analysis
    • COVID-19 Testing Drives Revenue Growth
    • Aging Population: A Prime Growth Driver
    • SELECT CE-IVD APPROVED MOLECULAR ASSAYS FOR COVID-19
    • TABLE 45: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 46: Europe 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2021 & 2027
    • TABLE 47: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 49: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 51: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • FRANCE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 54: France 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 55: France Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 57: France Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 58: France 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • GERMANY
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Germany 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 61: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 63: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Germany 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Italy 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 67: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 69: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 70: Italy 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • UNITED KINGDOM
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
    • Pandemic Exposes Deficiencies in the UK Healthcare System
    • UK Opens New Vaccine Centers to Expand Asymptomatic Covid-19 Testing
    • Mandatory COVID-19 Tests for UK-Bound Travellers
    • Mass Testing Program for COVID-19
    • Mass Testing in Schools
    • Mass Testing in Cities and Towns
    • New `Mega Labs` to Speed Up COVID-19 Testing in Early 2021
    • TABLE 71: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 72: UK 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 73: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 75: UK Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 76: UK 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 78: Spain 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 79: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Spain 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 81: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 82: Spain 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 84: Russia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 85: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Russia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 87: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Russia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Rest of Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 91: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 93: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 94: Rest of Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • ASIA-PACIFIC
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 96: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2021 & 2027
    • TABLE 97: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 99: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 100: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 102: Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • AUSTRALIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
    • TABLE 103: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Australia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 105: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 106: Australia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 107: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 108: Australia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • INDIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
    • Market Analysis
    • India Hastens Strides toward COVID-19 Testing & Significantly Exceeds Testing Criteria Set by WTO
    • Increase in Daily Tests for COVID-19 in India
    • Indian Researchers Develop Foremost Paper-based Test to Get Handle over COVID-19
    • Researchers in India Successfully Develop Saliva-based Test for COVID-19
    • Home Kits for COVID-19 Testing in India
    • The Rockefeller Foundation Injects New Grants to Boost Covid-19 Testing & Surveillance in India
    • TABLE 109: India Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: India 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 111: India Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 112: India 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 113: India Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 114: India 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • SOUTH KOREA
    • TABLE 115: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: South Korea 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 117: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 118: South Korea 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 120: South Korea 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
    • Authorities Succeed In Successfully Evading the Virus Impact
    • Widespread Roll Out of Testing Laboratories Yields Results
  • REST OF ASIA-PACIFIC
    • TABLE 121: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 123: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 126: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
    • Market Analysis
  • TAIWAN
    • Largest Outbreak of COVID-19 Infection in Taiwan led to Testing Backlog in the Country
  • INDONESIA
    • Indonesia Provided with 1 Million Antigen-Detecting Rapid Diagnostic Tests (Ag-RDTs)
  • LATIN AMERICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
    • TABLE 127: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 128: Latin America 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2021 & 2027
    • TABLE 129: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 130: Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 132: Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 133: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • ARGENTINA
    • TABLE 135: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 136: Argentina 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 138: Argentina 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 139: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Argentina 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • BRAZIL
    • TABLE 141: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 142: Brazil 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 144: Brazil 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 145: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Brazil 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • MEXICO
    • TABLE 147: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 148: Mexico 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 150: Mexico 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 151: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Mexico 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 153: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 154: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 156: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 157: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Rest of Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • MIDDLE EAST
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
    • TABLE 159: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 160: Middle East 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2021 & 2027
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 162: Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 163: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 165: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 166: Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 168: Iran 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 169: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Iran 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 171: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 172: Iran 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 174: Israel 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 175: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Israel 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 177: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 178: Israel 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 180: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 181: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 183: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 184: Saudi Arabia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • UNITED ARAB EMIRATES
    • New Testing Facilities Open Up in the UAE
    • TABLE 185: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 186: UAE 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 187: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: UAE 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 189: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 190: UAE 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 192: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 193: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 195: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 196: Rest of Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027
  • AFRICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
    • Market Analysis
    • WHO Pushes for Rapid Testing to Boost Africa's Response to COVID-19 Pandemic
    • COVID-19 Testing Benefits from Existing TB and HIV Laboratory Systems
    • RDTs Arrive in African Countries
    • TABLE 197: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 198: Africa 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2021 & 2027
    • TABLE 199: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Africa 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2021 & 2027
    • TABLE 201: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 202: Africa 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 547
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!